UK Patient Support Programs (PSP) Market
完整報告名稱與涵蓋範圍
UK Patient Support Programs (PSP) Market Size, Share & Trends Analysis Report, By Service Type (Homecare Medicines Delivery and Administration, Nurse-Led Adherence and Education Programs, Digital Patient Engagement and Remote Monitoring, Access, Reimbursement and Navigation Support), By Therapeutic Area (Immunology and Rheumatology, Oncology and Hematology, Rare Diseases and Specialty Therapies, Diabetes, Cardiometabolic and Respiratory Diseases), By Delivery Model (Pharma-Sponsored Programs, NHS-Commissioned Homecare Services, Hybrid and Third-Party Managed Programs), and Segment Forecasts, 2026-2035
報告摘要
The UK patient support programs market covers services commissioned by pharmaceutical companies and the National Health Service to help patients start and stay on specialty medicines, including clinical homecare delivery and administration, nurse-led adherence and education programs, digital engagement and remote monitoring and access-navigation support, across immunology, oncology, rare disease and chronic conditions. Clinical trials services and general pharmacy dispensing are excluded, and the analysis is confined to the United Kingdom.
Demand is driven by the growth of self-administered biologics and oral specialty therapies, by NHS strategies that move care from hospitals into homes and community settings, and by manufacturers seeking to protect persistence and outcomes for high-value products. The clinical homecare sector, which delivers medicines and nursing support to hundreds of thousands of patients, has faced scrutiny over service quality and financial resilience, leading to reforms in commissioning, contract standards and performance reporting that favour well-capitalised providers. Digital tools for symptom tracking, remote monitoring and virtual nursing are being integrated into programs, and regulatory codes governing manufacturer-sponsored services shape program design.
Activity concentrates in England, with devolved health services in Scotland, Wales and Northern Ireland following similar commissioning models. Competition involves specialist homecare providers, pharmacy groups, medical technology companies with infusion services and healthcare communications and data organisations.
The InsightAce study supplies US$ forecasts for all service type, therapeutic area and delivery model segments over 2026-2035, segment-level trend analysis, competitive landscape assessment and profiling of the leading companies.
授權報價
| Single User | $4,500 USD |
| Enterprise / Global Site Licence | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. UK Patient Support Programs (PSP) Market Snapshot
Chapter 4. UK Patient Support Programs (PSP) Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Market Drivers
4.3. Market Challenges
4.4. Emerging Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis - Porter's Five Forces Analysis
4.7. Competitive Landscape and Market Positioning
4.8. Market Opportunity Analysis
Chapter 5. Market Segmentation 1: By Service Type Estimates & Trend Analysis
5.1. Service Type & Market Share, 2026 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Service Type:
5.2.1. Homecare Medicines Delivery and Administration
5.2.2. Nurse-Led Adherence and Education Programs
5.2.3. Digital Patient Engagement and Remote Monitoring
5.2.4. Access, Reimbursement and Navigation Support
Chapter 6. Market Segmentation 2: By Therapeutic Area Estimates & Trend Analysis
6.1. Therapeutic Area & Market Share, 2026 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Therapeutic Area:
6.2.1. Immunology and Rheumatology
6.2.2. Oncology and Hematology
6.2.3. Rare Diseases and Specialty Therapies
6.2.4. Diabetes, Cardiometabolic and Respiratory Diseases
Chapter 7. Market Segmentation 3: By Delivery Model Estimates & Trend Analysis
7.1. Delivery Model & Market Share, 2026 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Delivery Model:
7.2.1. Pharma-Sponsored Programs
7.2.2. NHS-Commissioned Homecare Services
7.2.3. Hybrid and Third-Party Managed Programs
Chapter 8. UK Patient Support Programs (PSP) Market: Country Outlook & Operating Environment
8.1. Regulatory & Policy Framework
8.2. Pricing, Reimbursement & Procurement Environment
8.3. Demand Outlook & Adoption Trends, 2026-2035
Chapter 9. Competitive Landscape
9.1. Company Market Positioning Analysis
9.2. Strategic Developments (Partnerships, Expansions, Product Launches, M&A)
Chapter 10. Company Profiles
10.1. Sciensus Pharma Services Limited
10.2. LloydsPharmacy Clinical Homecare
10.3. HealthNet Homecare (UK) Limited
10.4. Pharmaxo Healthcare Ltd.
10.5. Alcura UK
10.6. Calea UK Limited
10.7. Baxter Healthcare Ltd.
10.8. B. Braun Medical Ltd.
10.9. Fresenius Medical Care UK
10.10. Bupa Home Healthcare
10.11. Ashfield Engage (Inizio)
10.12. IQVIA Ltd.
10.13. Vitaccess Ltd.
10.14. Huma Therapeutics Limited
10.15. Healthcare at Home Legacy Services
圖表清單 List of Tables & Figures
Table 1. UK Patient Support Programs (PSP) Market Revenue Forecast by Service Type, 2026-2035 (US$ Mn)
Figure 1. UK Patient Support Programs (PSP) Market Segmentation Overview
Table 2. UK Patient Support Programs (PSP) Market Revenue Forecast by Therapeutic Area, 2026-2035 (US$ Mn)
Figure 2. UK Patient Support Programs (PSP) Market Share by Service Type, 2026 & 2035
Table 3. UK Patient Support Programs (PSP) Market Revenue Forecast by Delivery Model, 2026-2035 (US$ Mn)
Figure 3. UK Patient Support Service Mix by Therapeutic Area and Delivery Model, 2026-2035
Table 4. UK Patient Support Programs (PSP) Market Revenue and Volume Snapshot, 2026-2035
Figure 4. UK Patient Support Programs (PSP) Market Share by Therapeutic Area, 2026 & 2035
Table 5. Strategic Developments of Leading UK Patient Support Programs (PSP) Market Participants, 2023-2026
Figure 5. Clinical Homecare Commissioning Reforms and Provider Consolidation
Figure 6. UK Patient Support Programs (PSP) Market Growth Opportunity Analysis by Segment, 2026-2035
Figure 7. Digital Engagement and Remote Monitoring Integration into UK Support Programs
Figure 8. Competitive Positioning of Key UK Patient Support Programs (PSP) Market Participants
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們